HopeStage
Back to all studies
Not recruitingISRCTN69461593

QbTest Utility for Optimising Treatment in ADHD (QUOTA)

Research studyAges 18–17United Kingdom
The study in practice

Understand this study

Who could participate?

This study is for people with ADHD. Listed age limits: 18 years to 17 years. Other eligibility criteria apply.

Get this study by email

HopeStage may email me about this study.
Loading the security check...

What to know before participating

A point to clarify

This summary does not cover all risks or eligibility requirements. What risks or changes to my care would apply to me?

Study clarity

Things to check before joining

Study start dateStarted: December 1, 2017
Recruitment status
Not recruiting
Enrollment listed in the registry
Not clearly listed
Sponsor
Nottinghamshire Healthcare NHS Foundation Trust
Sponsor type
Non-profit organization
Study type
Other
Intervention type
Other / unclear
Locations
United Kingdom
Age range
From 18 Years to 17 Years
Official registry ID
ISRCTN69461593
Official title
Show the full official title

Optimising Medication Management in Children and Young People With Attention Deficit Hyperactivity Disorder (ADHD) Using an Objective Measure of Attention, Impulsivity and Activity (QbTest): a Feasibility Study

Recruitment & locations

Not recruiting

Nottingham

Interested in joining this study?

HopeStage may email me about this study.
Loading the security check...
FAQ

Questions about this study

Who is behind this study?

The study sponsor is Nottinghamshire Healthcare NHS Foundation Trust.

Who can participate?

This study is for people with ADHD. Listed age limits: 18 years to 17 years. Other eligibility criteria apply.

Is this study still recruiting?

The registry lists this study as not recruiting.

Want to explore more studies?

Explore studies